First Light Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9M | Buy |
|
|||||
|
2025
Q1 | $28.7M | Sell |
|
|||||
|
2024
Q4 | $45.3M | Sell |
|
|||||
|
2024
Q3 | $48.2M | Sell |
|
|||||
|
2024
Q2 | $53.8M | Sell |
|
|||||
|
2024
Q1 | $79.1M | Sell |
|
|||||
|
2023
Q4 | $70.7M | Buy |
|
|||||
|
2023
Q3 | $47.1M | Buy |
|
|||||
|
2023
Q2 | $28.1M | Sell |
|
|||||
|
2023
Q1 | $26M | Buy |
|
|||||
|
2022
Q4 | $24.3M | Sell |
|
|||||
|
2022
Q3 | $26.4M | Buy |
|
|||||
|
2022
Q2 | $23.1M | Buy |
|
|||||
|
2022
Q1 | $12.8M | Buy |
|
|||||
|
2021
Q4 | $7.75M | Buy |
|